.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer last year for a whopping $43 b...
.On the heels of a period 3 succeed that failed to excite financiers, Ironwood Pharmaceuticals is ba...
.Don't stop Monte Rosa Rehabs now. The Boston-based biotech is actually having a ball after signing ...
.Invite to today's Chutes & Ladders, our summary of notable management hirings, shootings and als...
.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...
.AbbVie has come back to the resource of its own antipsychotic goliath Vraylar trying to find an add...
.GenSight Biologics is actually full weeks away from lacking loan. Again. The biotech merely has eno...
.Monopar Therapeutics is recuperating a drug from the dump of AstraZeneca's rare health condition pi...
.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...
.After forming a gene therapy collaboration along with Dyno Therapeutics in 2020, Roche is back for ...